JP2023542301A5 - - Google Patents

Info

Publication number
JP2023542301A5
JP2023542301A5 JP2023516505A JP2023516505A JP2023542301A5 JP 2023542301 A5 JP2023542301 A5 JP 2023542301A5 JP 2023516505 A JP2023516505 A JP 2023516505A JP 2023516505 A JP2023516505 A JP 2023516505A JP 2023542301 A5 JP2023542301 A5 JP 2023542301A5
Authority
JP
Japan
Prior art keywords
adc
cancer
cell
antibody
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023516505A
Other languages
English (en)
Japanese (ja)
Other versions
JP7829563B2 (ja
JP2023542301A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/075116 external-priority patent/WO2022053685A2/en
Publication of JP2023542301A publication Critical patent/JP2023542301A/ja
Publication of JP2023542301A5 publication Critical patent/JP2023542301A5/ja
Application granted granted Critical
Publication of JP7829563B2 publication Critical patent/JP7829563B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023516505A 2020-09-12 2021-09-13 抗b7h4抗体薬物コンジュゲート療法のためのスコア化方法 Active JP7829563B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063077607P 2020-09-12 2020-09-12
US63/077,607 2020-09-12
PCT/EP2021/075116 WO2022053685A2 (en) 2020-09-12 2021-09-13 A scoring method for an anti-b7h4 antibody-drug conjugate therapy

Publications (3)

Publication Number Publication Date
JP2023542301A JP2023542301A (ja) 2023-10-06
JP2023542301A5 true JP2023542301A5 (cg-RX-API-DMAC7.html) 2024-09-12
JP7829563B2 JP7829563B2 (ja) 2026-03-13

Family

ID=77913114

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023516505A Active JP7829563B2 (ja) 2020-09-12 2021-09-13 抗b7h4抗体薬物コンジュゲート療法のためのスコア化方法

Country Status (10)

Country Link
US (1) US20240302348A1 (cg-RX-API-DMAC7.html)
EP (2) EP4211663B1 (cg-RX-API-DMAC7.html)
JP (1) JP7829563B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230066095A (cg-RX-API-DMAC7.html)
CN (1) CN116615455A (cg-RX-API-DMAC7.html)
AU (1) AU2021342349B2 (cg-RX-API-DMAC7.html)
CA (1) CA3194182A1 (cg-RX-API-DMAC7.html)
ES (1) ES3066663T3 (cg-RX-API-DMAC7.html)
IL (1) IL301264A (cg-RX-API-DMAC7.html)
WO (1) WO2022053685A2 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115160403B (zh) * 2022-07-05 2025-06-27 博石丰生命科技(南通)有限公司 特异性拓扑异构酶抑制剂和可用于抗体药物偶联物及其制备方法
CN119818693A (zh) 2023-10-13 2025-04-15 华东师范大学 一种用于前药给药系统的可裂解支链连接体化合物及其制备和应用

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US6492107B1 (en) 1986-11-20 2002-12-10 Stuart Kauffman Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique
DE3587814T2 (de) 1985-03-30 1994-11-10 Marc Ballivet Verfahren zum erhalten von dns, rns, peptiden, polypeptiden oder proteinen durch dns-rekombinant-verfahren.
US5618920A (en) 1985-11-01 1997-04-08 Xoma Corporation Modular assembly of antibody genes, antibodies prepared thereby and use
DE3600905A1 (de) 1986-01-15 1987-07-16 Ant Nachrichtentech Verfahren zum dekodieren von binaersignalen sowie viterbi-dekoder und anwendungen
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
CA2016841C (en) 1989-05-16 1999-09-21 William D. Huse A method for producing polymers having a preselected activity
EP0478627A4 (en) 1989-05-16 1992-08-19 William D. Huse Co-expression of heteromeric receptors
CA2016842A1 (en) 1989-05-16 1990-11-16 Richard A. Lerner Method for tapping the immunological repertoire
US6172197B1 (en) 1991-07-10 2001-01-09 Medical Research Council Methods for producing members of specific binding pairs
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
ES2246502T3 (es) 1990-08-29 2006-02-16 Genpharm International, Inc. Animales no humanos transgenicos capaces de producir anticuerpos heterologos.
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
DE69129154T2 (de) 1990-12-03 1998-08-20 Genentech, Inc., South San Francisco, Calif. Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften
PT1024191E (pt) 1991-12-02 2008-12-22 Medical Res Council Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos
WO1993011794A1 (en) 1991-12-13 1993-06-24 Xoma Corporation Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
US5639641A (en) 1992-09-09 1997-06-17 Immunogen Inc. Resurfacing of rodent antibodies
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
EP0859841B1 (en) 1995-08-18 2002-06-19 MorphoSys AG Protein/(poly)peptide libraries
US6828422B1 (en) 1995-08-18 2004-12-07 Morphosys Ag Protein/(poly)peptide libraries
US5714352A (en) 1996-03-20 1998-02-03 Xenotech Incorporated Directed switch-mediated DNA recombination
ATE482275T1 (de) 1999-07-02 2010-10-15 Morphosys Ag Erzeugung spezifischer bindungspartner die an von genomischen dns-fragmenten oder ests kodierten (poly)peptiden binden
US7538195B2 (en) 2002-06-14 2009-05-26 Immunogen Inc. Anti-IGF-I receptor antibody
DK1578446T3 (en) 2002-11-07 2015-06-29 Immunogen Inc ANTI-CD33 ANTIBODIES AND PROCEDURES FOR TREATING ACUTE MYELOID LEUKEMIA BY USING IT
DE602006012816D1 (de) * 2005-03-30 2010-04-22 Endocyte Inc Tifizierung von zellulären folat vitamin rezeptoren
AR069747A1 (es) 2007-11-30 2010-02-17 Medarex Inc Conjugado anticuerpo monoclonal anti-b7h4- farmaco y metodos de utilizacion
JP5470817B2 (ja) 2008-03-10 2014-04-16 日産自動車株式会社 電池用電極およびこれを用いた電池、並びにその製造方法
WO2012133047A1 (ja) * 2011-03-25 2012-10-04 コニカミノルタエムジー株式会社 免疫組織染色法、およびこれを用いた抗体医薬の有効性を判定する方法
ES2661466T3 (es) * 2011-04-01 2018-04-02 Immunogen, Inc. Métodos para aumentar la eficacia de la terapia contra el cáncer con FOLR1
US9676854B2 (en) 2011-08-15 2017-06-13 Medimmune, Llc Anti-B7-H4 antibodies and their uses
EP2832845A1 (en) * 2012-03-30 2015-02-04 Kanagawa Academy Of Science And Technology Imaging cell sorter
JP6136279B2 (ja) 2013-01-15 2017-05-31 株式会社ジェイテクト 転がり軸受装置
MX2015010777A (es) * 2013-03-14 2016-04-25 Genentech Inc Anticuerpos e inmunoconjugados anti-b7-h4.
TWI503850B (zh) 2013-03-22 2015-10-11 Polytronics Technology Corp 過電流保護元件
TWI510996B (zh) 2013-10-03 2015-12-01 Acer Inc 控制觸控面板的方法以及使用該方法的可攜式電腦
JP6604960B2 (ja) 2014-02-21 2019-11-13 ベンタナ メディカル システムズ, インコーポレイテッド バイオマーカー陽性の腫瘍細胞を識別するための医用画像解析
US10613092B2 (en) * 2016-04-01 2020-04-07 Agilent Technologies, Inc. Scoring methods for anti-PD therapy eligibility and compositions for performing same
RS61659B1 (sr) 2016-05-17 2021-04-29 Abbvie Biotherapeutics Inc Konjugati antitelo lek anti-cmet i metode za njihovu upotrebu
US9816280B1 (en) 2016-11-02 2017-11-14 Matthew Reitnauer Portable floor
EP3539080B1 (en) * 2016-11-10 2022-03-23 F. Hoffmann-La Roche AG Distance-based tumor classification
WO2019197509A1 (en) * 2018-04-13 2019-10-17 Ventana Medical Systems, Inc. Systems for cell shape estimation
US11030744B2 (en) * 2018-06-26 2021-06-08 Astrazeneca Computational Pathology Gmbh Deep learning method for tumor cell scoring on cancer biopsies
WO2020023213A1 (en) 2018-07-27 2020-01-30 Ventana Medical Systems, Inc. Systems for automated in situ hybridization analysis
EP3867803A1 (en) * 2018-10-15 2021-08-25 Ventana Medical Systems, Inc. Systems and methods for cell classification
AU2020288275A1 (en) * 2019-06-06 2022-02-03 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Anti-B7-H4 antibody–drug conjugate and medicinal use thereof

Similar Documents

Publication Publication Date Title
US20260139067A1 (en) Cdcp1 antibodies and antibody drug conjugates
JP2023545359A5 (cg-RX-API-DMAC7.html)
EP2624866A2 (en) Tumor specific antibodies and uses therefor
AU2021340002B9 (en) A scoring method for an anti-her2 antibody-drug conjugate therapy
JP7105304B2 (ja) 尿路上皮がんの治療における抗her2抗体-薬物コンジュゲートの使用
US11851496B2 (en) Antibodies against the human fshr extracellular domain
BR112020001657A2 (pt) Anticorpo contra cd147 humana, fragmento de ligação a antígeno do anticorpo, composição farmacêutica, uso do anticorpo ou do fragmento de ligação a antígeno,polinucleotídeo, vetor de expressão, célula hospedeira, método para produzir o anticorpo ou o fragmento de ligação a antígeno do mesmo, para prognosticar aresponsividade ao tratamento contra o câncer e para selecionar sujeitos para o tratamento contra o câncer, kit para determinar a responsividade ao tratamento contra o câncer, complexo de anticorpo-fármaco, e, anticorpo biespecífico
WO2023131193A1 (zh) 靶向人b7-h3分子的人源化单克隆抗体及其应用
US20190106507A1 (en) Antibody-drug conjugates containing anti-globo h antibodies and uses thereof
JP2024545428A5 (cg-RX-API-DMAC7.html)
EP4198054A1 (en) Anti-hmmw antibody, composition containing same, nucleic acid molecule encoding same, and use thereof
JP2023546357A (ja) ベネトクラクス-抵抗性急性骨髄性白血病の対象特異的治療
JP2025509564A5 (cg-RX-API-DMAC7.html)
JP2025509564A (ja) 抗trop2抗体-薬物コンジュゲート治療のためのスコアリング方法
JP5090342B2 (ja) 膵臓癌の診断薬及び治療薬
AU2019228339A1 (en) Progastrin as a biomarker for immunotherapy
EP2594943A1 (en) Method for detecting malignant tumor cells
CN116920112A (zh) Icam1或其编码基因在制备胃癌治疗或诊断产品中的用途
Kaczmar et al. Phase 2 trial of nivolumab, an anti-PD-1 monoclonal antibody, as a novel neoadjuvant pre-surgical therapy for locally advanced oral cavity cancer
CN120053679A (zh) 一种靶向CD66c的抗体偶联药物及其在制备胃食管结合部癌治疗药物中的用途
JP2025528148A (ja) クローディン-6抗体及びそのコンジュゲート及び使用
WO2025095142A1 (ja) 光免疫療法
Chen Application of Engineered Fully Human Monoclonal Antibodies in Tumor Treatment and Diagnosis
CN117015386A (zh) 细胞周转因子用于增加组织再生的用途
WO2026052046A1 (zh) 抗Claudin18.2抗体药物偶联物用于治疗胃癌和/或胃食管结合部腺癌的用途